Quantcast

Latest Diabetes mellitus type 1 Stories

FDA Approves Novel AstraZeneca, Bristol-Meyers Squibb Diabetes Drug
2014-01-10 11:37:58

Ranjini Raghunath for redOrbit.com - Your Universe Online The FDA has approved the use of a new Type 2 diabetes drug called Farxiga, developed by pharmaceutical companies Bristol-Meyers Squibb and AstraZeneca. Type 2 diabetes affects 24 million people in the US and nearly 350 million people worldwide. Conventional diabetes drugs work by reducing the amount of sugar the body absorbs from food or by boosting the production of insulin which disposes of excess sugar. Farxiga, however,...

2014-01-09 08:28:46

Renewed commitment over two years helps support education for students with type 1 diabetes INDIANAPOLIS and ROLLING MEADOWS, Ill., Jan. 9, 2014 /PRNewswire/ -- Today Lilly Diabetes announced it will renew its commitment to the Diabetes Scholars Foundation (Foundation) scholarship fund for another two years. The commitment includes a $200,000 donation ($100,000 for each calendar year) that will support the Foundation's mission: to empower young people with type 1 diabetes to live...

2014-01-08 08:29:12

Dr. Ken Moritsugu, Dayton Coles, Robert Geho Strengthen Foundation's Commitment to Patient-centered Diabetes Advocacy BERKELEY, Calif., Jan. 8, 2014 /PRNewswire-iReach/ -- Diabetes Hands Foundation (DHF) announced the election of Dr. Ken Moritsugu, Dayton Coles, and Robert Geho to the organization's board of directors. Collectively these new directors strengthen the foundation's commitment to patient-centered diabetes advocacy. Each brings personal experience as a diabetes patient,...

2014-01-08 08:27:23

- JHL Biotech to develop and commercialize BL-9020 in China and additional Southeast Asia countries - JERUSALEM and HSINCHU, Taiwan, Jan. 8, 2014 /PRNewswire/ -- BioLineRx (NASDAQ: BLRX; TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, and JHL Biotech, a biopharmaceutical company that develops, manufactures, and commercializes biologic medicines, announced today that they have entered into...

2014-01-07 12:27:29

LONDON, Jan. 7, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: MarketVIEW: diabetes vaccines Diabetes is a metabolic disorder where the pancreas produces little or no insulin (Type I) OR cells do not respond appropriately to insulin that is produced (Type II). It is estimated that the global prevalence of diabetes is estimated at over 371 million people, a number predicted to rise significantly by 2030. Diabetes, although manageable, can lead to a...

2014-01-07 12:27:22

--Research program will investigate an exciting new hypothesis about lost beta cell function in type 1 diabetes that may change our basic understanding of the disease and lead to novel prevention and restoration therapies-- NEW YORK, Jan. 7, 2014 /PRNewswire-USNewswire/ -- JDRF announced today the funding of an approximately $1 million collaboration with the University of Michigan's Brehm Center and the Brehm Coalition to evaluate a new hypothesis on why beta cells lose their ability...

2014-01-06 08:25:03

EDGEWATER, N.J., Jan. 6, 2014 /PRNewswire/ -- DiaVacs, Inc. announced today that the Office of Orphan Products Development of the Food and Drug Administration (FDA) has granted orphan drug designation for the company's type 1 diabetes mellitus (T1DM) therapy. DV-0100 is proprietary, novel and safe. The therapy halt's the body's autoimmune reaction against the pancreatic islet cells which are responsible for producing insulin, thus allowing them to produce insulin normally and...

2014-01-02 08:23:12

JERUSALEM, January 2, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. [http://www.oramed.com ] (NASDAQCM: ORMP) ( http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has received Notices of Allowance from the Israel and Australian Patent Office [http://www.ilpatsearch.justice.gov.il/UI/RequestDetails.aspx?ReqId=208165 ]s. The patent entitled, "Methods and Compositions for Oral Administrations of Proteins" covers a core concept...

2013-12-28 23:02:58

Reverse Your Diabetes Today is a new and safe diabetes cure that is created by Matt Traverso that claims to help people cure their diabetes quickly. A full Reverse Your Diabetes Today review on the site hynguyenblog.com shows whether this method is reliable to use. (PRWEB) December 28, 2013 Reverse Your Diabetes Today is a newly updated diabetes cure developed by Matt Traverso that claims to help patients banish their diabetes forever. This natural home remedy promises to heal this...


Latest Diabetes mellitus type 1 Reference Libraries

Diabetes (journal)
2012-05-12 21:44:48

Diabetes is a peer-reviewed medical journal published since 1952 by the American Diabetes Association. Diabetes is a separate journal from the journal Diabetes Care, which is also published by the ADA. Diabetes covers research about the physiology and pathophysiology of diabetes mellitus, including any aspect of laboratory, animal or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic...

More Articles (1 articles) »
Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.